Discover Tenders by Ash Residues Containing Copper Sector

Find the most relevant tenders for Ash Residues Containing Copper. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Ash Residues Containing Copper tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Ash Residues Containing Copper tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Naproxen Excluding The Syrup Dosage Form Atc Code According To Who M01Ae

Deadline: 31 Aug 2026

Germany

Ref. No.: 7191964

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Tacrolimus Atc L04Ad02 Obo For The Period 01 09 2024 31 08 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2026

Germany

Ref. No.: 7191811

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Olopatadine Atc S01Gx09 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7190250

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Febuxostat Atc Code According To Who M04Aa03

Deadline: 30 Sep 2026

Germany

Ref. No.: 7189556

EMD:Ref Document

Bid Value: Ref Document

347 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Chlorthalidone Atc C03Ba04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7189539

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Capsaicin Atc N01Bx04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7186844

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Milnacipran Atc N06Ax17 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7175295

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Miglustat Atc Code According To Who A16Ax06

Deadline: 31 Aug 2026

Germany

Ref. No.: 7169020

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In Dafo Injection Solution Atc L04Aa23 Obo For The Period 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7164900

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Open House Original Rebate Agreements 2024 06 Aclidinium Bromide Formoterol Active Ingredient Combination

Deadline: 31 Aug 2026

Germany

Ref. No.: 7154440

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Dexamethasone Atc Code H02Ab02 That Can Be Prescribed And Dispensed As Part Of The Consultation Hou

Deadline: 27 Jun 2026

Germany

Ref. No.: 7146194

EMD:Ref Document

Bid Value: Ref Document

252 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Propofol Atc Code N01Ax10 That Can Be Prescribed And Dispensed As Part Of The Outpatient Needs In L

Deadline: 27 Jun 2026

Germany

Ref. No.: 7145649

EMD:Ref Document

Bid Value: Ref Document

252 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Evolocumab C10Ax13 Within The Framework Of A So Called Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110598

EMD:Ref Document

Bid Value: Ref Document

256 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lanthanum Iii Carbonate Chewable Tablets Only V03Ae03 Within The Framework Of A So

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110380

EMD:Ref Document

Bid Value: Ref Document

256 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Rivaroxaban Atc B01Af01 In The Active Strength 2 5 Mg Per Divided Oral Dosage Form

Deadline: 27 Jun 2026

Germany

Ref. No.: 6914003

EMD:Ref Document

Bid Value: Ref Document

252 Days Left

Showing 19861 to 19875 of 20011 results

‹
1
2
...
1322
1323
1324
1325
1326
1327
1328
...
1334
1335
›

Discover Tenders by Ash Residues Containing Copper Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Ash Residues Containing Copper Sector

Filter Your Search

FREE Trial plan for all new users!